BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nunes P, Correia I, Cavaco I, Marques F, Pinheiro T, Avecilla F, Pessoa JC. Therapeutic potential of vanadium complexes with 1,10-phenanthroline ligands, quo vadis? Fate of complexes in cell media and cancer cells. J Inorg Biochem 2021;217:111350. [PMID: 33477088 DOI: 10.1016/j.jinorgbio.2020.111350] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 24.0] [Reference Citation Analysis]
Number Citing Articles
1 Ramón LA, de la Cruz Hernández EN, González RL, Landero MFH, Owen PQ, Mendoza CG, Mendoza GM, Lemus MAA. Antiproliferative effect of 1,10-Phenanthroline coupled to sulfated ZnO nanoparticles in SiHa cervix cancer cell line. J Sol-Gel Sci Technol. [DOI: 10.1007/s10971-022-05922-w] [Reference Citation Analysis]
2 Patra SA, Banerjee A, Sahu G, Mohanty M, Lima S, Mohapatra D, Görls H, Plass W, Dinda R. Evaluation of DNA/BSA interaction and in vitro cell cytotoxicity of μ2-oxido bridged divanadium(V) complexes containing ONO donor ligands. Journal of Inorganic Biochemistry 2022;233:111852. [DOI: 10.1016/j.jinorgbio.2022.111852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Santos MFA, Sciortino G, Correia I, Fernandes ACP, Santos-Silva T, Pisanu F, Garribba E, Costa Pessoa J. Binding of VIV O2+ , VIV OL, VIV OL2 and VV O2 L Moieties to Proteins: X-ray/Theoretical Characterization and Biological Implications. Chemistry 2022;28:e202200105. [PMID: 35486702 DOI: 10.1002/chem.202200105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ribeiro N, Bulut I, Pósa V, Sergi B, Sciortino G, Pessoa JC, Maia LB, Ugone V, Garribba E, Enyedy ÉA, Acilan C, Correia I. Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes. Journal of Inorganic Biochemistry 2022. [DOI: 10.1016/j.jinorgbio.2022.111932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Matos CP, Albino M, Lopes J, Viana AS, Côrte-Real L, Mendes F, Pessoa JC, Tomaz AI, Reis CP, Gaspar MM, Correia I. New iron(III) anti-cancer aminobisphenolate/phenanthroline complexes: Enhancing their therapeutic potential using nanoliposomes. Int J Pharm 2022;623:121925. [PMID: 35718249 DOI: 10.1016/j.ijpharm.2022.121925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Patra D, Pal A, Nath S, Kundu R, Drew MGB, Ghosh T. Insights into the transformation of VO2+ motif to VO3+, V2O34+ and VO2+ motifs and their interconversion along with a detailed mechanistic study of their anti-cancer activity in SiHa cervical cancer cells. J Inorg Biochem 2022;234:111900. [PMID: 35717882 DOI: 10.1016/j.jinorgbio.2022.111900] [Reference Citation Analysis]
7 Lima S, Banerjee A, Sahu G, Patra SA, Sahu K, Sasamori T, Sciortino G, Garribba E, Dinda R. New mixed ligand oxidovanadium(IV) complexes: Solution behavior, protein interaction and cytotoxicity. Journal of Inorganic Biochemistry 2022. [DOI: 10.1016/j.jinorgbio.2022.111853] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Ugone V, Pisanu F, Garribba E. Interaction of pharmacologically active pyrone and pyridinone vanadium(IV,V) complexes with cytochrome c. Journal of Inorganic Biochemistry 2022. [DOI: 10.1016/j.jinorgbio.2022.111876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Levina A, Crans DC, Lay PA. Advantageous Reactivity of Unstable Metal Complexes: Potential Applications of Metal-Based Anticancer Drugs for Intratumoral Injections. Pharmaceutics 2022;14:790. [DOI: 10.3390/pharmaceutics14040790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Arhouma Z, Murakami HA, Koehn JT, Li X, Roess DA, Crick DC, Crans DC. Exploring Growth of Mycobacterium smegmatis Treated with Anticarcinogenic Vanadium Compounds. Inorganics 2022;10:50. [DOI: 10.3390/inorganics10040050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Sahu G, Patra SA, Mohanty M, Lima S, Pattanayak PD, Kaminsky W, Dinda R. Dithiocarbazate based oxidomethoxidovanadium(V) and mixed-ligand oxidovanadium(IV) complexes: Study of solution behavior, DNA binding, and anticancer activity. Journal of Inorganic Biochemistry 2022. [DOI: 10.1016/j.jinorgbio.2022.111844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mohanty M, Sahu G, Banerjee A, Lima S, Patra SA, Crochet A, Sciortino G, Sanna D, Ugone V, Garribba E, Dinda R. Mo(VI) Potential Metallodrugs: Explaining the Transport and Cytotoxicity by Chemical Transformations. Inorg Chem 2022. [PMID: 35213131 DOI: 10.1021/acs.inorgchem.2c00113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Damena T, Zeleke D, Desalegn T, Demissie TB, Eswaramoorthy R. Synthesis, Characterization, and Biological Activities of Novel Vanadium(IV) and Cobalt(II) Complexes. ACS Omega 2022;7:4389-404. [PMID: 35155932 DOI: 10.1021/acsomega.1c06205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Sabar SS, Alajrawy OI, Elbohy SA, Sharaby CM. New molybdenum(VI) and vanadium(IV) complexes with 3-aminopyridine and dithiooxamide ligands spectroscopic characterization, DFT calculations, and in vitro cytotoxic activity. Materials Today: Proceedings 2022;65:2537-2550. [DOI: 10.1016/j.matpr.2022.04.725] [Reference Citation Analysis]
15 Actis Dato A, Naso LG, Rey M, Gonzalez PJ, Ferrer EG, Williams PAM. Phenanthroline Complexation Enhances the Cytotoxic Activity of the VO-Chrysin System. Inorganics 2022;10:4. [DOI: 10.3390/inorganics10010004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Pessoa JC, Santos MF, Correia I, Sanna D, Sciortino G, Garribba E. Binding of vanadium ions and complexes to proteins and enzymes in aqueous solution. Coordination Chemistry Reviews 2021;449:214192. [DOI: 10.1016/j.ccr.2021.214192] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
17 Nunes P, Yildizhan Y, Adiguzel Z, Marques F, Costa Pessoa J, Acilan C, Correia I. Copper(II) and oxidovanadium(IV) complexes of chromone Schiff bases as potential anticancer agents. J Biol Inorg Chem 2021. [PMID: 34817681 DOI: 10.1007/s00775-021-01913-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
18 Corona-motolinia ND, Martínez-valencia B, Noriega L, Sánchez-gaytán BL, Mendoza A, Meléndez-bustamante FJ, Castro ME, González-vergara E. Ternary Copper Complex of L-Glutamine and Phenanthroline as Counterions of Cyclo-Tetravanadate Anion: Experimental–Theoretical Characterization and Potential Antineoplastic Activity. Metals 2021;11:1541. [DOI: 10.3390/met11101541] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Patra SA, Mohanty M, Banerjee A, Kesarwani S, Henkel F, Reuter H, Dinda R. Protein binding and cytotoxic activities of monomeric and dimeric oxido-vanadium(V) salan complexes: Exploring the solution behavior of monoalkoxido-bound oxido-vanadium(V) complex. J Inorg Biochem 2021;224:111582. [PMID: 34450411 DOI: 10.1016/j.jinorgbio.2021.111582] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
20 Ugone V, Pisanu F, Sanna D, Garribba E. Interaction of the potent antitumoral compounds Casiopeinas® with blood serum and cellular bioligands. J Inorg Biochem 2021;224:111566. [PMID: 34418714 DOI: 10.1016/j.jinorgbio.2021.111566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Ahmed TT, Alajrawy OI. Oxovanadinum (IV) complexes with bidentate ligands synthesis, characterization, and comparison between experimental and theoretical. Materials Today: Proceedings 2021. [DOI: 10.1016/j.matpr.2021.07.396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Rudbari HA, Saadati A, Aryaeifar M, Correia I, Marques F, Blacque O, Micale N. Cytotoxic oxidovanadium(IV) complexes of tridentate halogen-substituted Schiff bases: First dinuclear V(IV) complexes with O → VIV = O → VIV = O core. Bioorg Med Chem Lett 2021;49:128285. [PMID: 34303813 DOI: 10.1016/j.bmcl.2021.128285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Pessoa JC, Correia I. Misinterpretations in Evaluating Interactions of Vanadium Complexes with Proteins and Other Biological Targets. Inorganics 2021;9:17. [DOI: 10.3390/inorganics9020017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 28.0] [Reference Citation Analysis]